CVS to close 22 stores; CRISPR passes safety test; Kentucky Gov.-elect to rescind Medicaid work requirement.
Walgreens seeking private equity buyer; People increasingly turning to Google, social media for medical advice; White House will not support Nancy Pelosi’s drug pricing bill.
Religious exemptions for vaccines have risen; FDA’s decision on Biogen Alzheimer’s drug may be political; Shortage of immune globulin affects cancer, epilepsy treatments.
MM&M and PRWeek unveil the 2019 Health Influencer 50; Google acquires Fitbit; President Donald Trump nominates Dr. Stephen Hahn as FDA lead.
Some Democrats shift message on drug-price legislation; Vaping deaths rise to 37; FTC investigates Altria role in replacing Juul CEO.
Former Juul executive sues company; Purdue financial details revealed; Amgen cuts 180 jobs.
After tests, J&J says recalled baby powder doesn’t have asbestos; Federal judge blocks Alabama abortion law; Marketing chief, other execurives depart Juul.
Facebook’s big announcement at HLTH; Report: Google parent makes bid for Fitbit; Walgreens to close 150 clinics.
Government warns of hospital equipment shortages; Panel says Pelosi drug price bill could be unconstitutional; Fewer cases of vaping illness reported.
Verily partners with Palo Alto VA; Amgen drops list price of Repatha; Amazon acquires Health Navigator.
Nancy Pelosi’s drug price bill heads to full vote; FDA proposes cancer warnings on breast implants; NIH, Gates Foundation pledge $200 million to HIV, sickle cell cures.
Biogen resurrects Alzheimer’s drug in light of new analysis; ACA premiums expected to drop next year; Novartis gene therapy Zolgensma beats sales expectations.